Evaluating MOTS-c peptide cost requires examining synthesis standards, analytical purity verification, and batch-to-batch consistency for preclinical applications. At PX1 Research, we provide laboratory-grade compounds supported by lot-specific analytical documentation to ensure reproducible experimental results.
Evaluating MOTS-c peptide cost requires examining synthesis standards, analytical purity verification, and batch-to-batch consistency for preclinical applications. At PX1 Research, we provide laboratory-grade compounds supported by lot-specific analytical documentation to ensure reproducible experimental results.
The market cost of MOTS-c research peptide reflects solid-phase peptide synthesis (SPPS) parameters, purification complexity, and rigorous analytical quality control standards. High-purity MOTS-c sequence production mandates precise coupling procedures to avoid deletion sequences and truncated byproducts, directly impacting overall manufacturing overhead and final analytical validation costs.
When procurement departments evaluate vendor pricing, cost variations generally track with HPLC purity verification metrics, mass spectrometry confirmation, and endotoxin testing limits. Incompletely purified reagents or compounds lacking lot-specific certificates of analysis (COAs) often exhibit lower initial unit pricing but present substantial risks of experimental confounding in mitochondrial and metabolic assays.
MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid mitochondrial-derived peptide (MDP) encoded within the mitochondrial genome. Unlike nuclear-encoded signaling molecules, MOTS-c originates directly within the mitochondrial matrix, representing a unique class of retrograde signaling agents that communicate mitochondrial metabolic status to nuclear transcription machinery.
In structural assays, the peptide demonstrates amphipathic alpha-helical potential that facilitates interaction with intracellular targets. Researchers interested in broader signaling cascades frequently compare MOTS-c against other mitochondrial-derived peptides to determine structural determinants of metabolic control, nuclear translocation rates, and receptor binding affinities across diverse tissue explants.
Primary determinants of MOTS-c pricing include raw material purity, automated synthesizer run size, post-synthesis preparative HPLC purification steps, and freeze-drying optimization. Achieving a standardized purity threshold above 98% requires multiple chromatographic passes, which reduces total mass yield per run but yields the chemical uniformity necessary for quantitative cell culture and animal model experimentation.
Additionally, rigorous quality control protocols contribute significantly to manufacturing economics. Facilities operating under GMP compliance standards utilize ISO 17025 accredited laboratories to perform high-performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESI-MS). Inferior compounds sold without detailed analytical validation often harbor residual trifluoroacetic acid (TFA) salts, heavy metal traces, or bacterial endotoxins that distort cellular respiration assays.
Preclinical studies indicate that MOTS-c functions as a key regulator of systemic energy homeostasis by targeting metabolic pathways in skeletal muscle and hepatic tissues. In vitro assays demonstrate that administration of synthetic MOTS-c activates 5'-AMP-activated protein kinase (AMPK), a master regulator of cellular energy balance, independent of classic upstream signaling molecules like LKB1.
In cell culture models, MOTS-c treatment enhances glucose uptake via upregulation of glucose transporter 4 (GLUT4) translocation. Furthermore, preclinical models evaluating metabolic stress show that MOTS-c suppresses the folate cycle and methionine biosynthesis, leading to elevated levels of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and downstream AMPK activation. These mechanistic pathways position MOTS-c as a primary candidate for investigations into insulin sensitivity and cellular bioenergetics.
In vivo investigations utilizing rodent models have highlighted the role of MOTS-c in modulating exercise capacity and physical performance metrics. Preclinical data show that intraperitoneal or subcutaneous administration of MOTS-c in mice enhances exercise performance, oxygen consumption rates, and energy expenditure during treadmill exhaustion trials.
Mechanistically, rodent studies reveal that MOTS-c translocates to the nucleus during metabolic stress or physical exertion, where it binds to antioxidant response elements (ARE) and interacts with transcription factors such as NRF2. This nuclear translocation promotes the transcription of cytoprotective and antioxidant genes, thereby maintaining mitochondrial membrane potential and reducing oxidative stress during forced exertion protocols.
When structuring comparative research models, investigators frequently evaluate MOTS-c alongside other bioenergetic and cytoprotective compounds. For example, Humanin represents another classic mitochondrial-derived peptide involved in anti-apoptotic pathways and metabolic survival signaling, though its structural motif and specific nuclear targets differ from MOTS-c.
Similarly, targeted compounds such as SS-31 (Elamipretide) interact directly with cardiolipin in the inner mitochondrial membrane to optimize electron transport chain efficiency, whereas MOTS-c primarily influences nuclear gene expression via metabolic pathway cross-talk. Researchers seeking to evaluate the entire scope of mitochondrial regulators can review our full catalog of research peptides for complementary experimental designs.
To guarantee experimental consistency, procurement specialists must demand lot-specific documentation prior to purchasing MOTS-c. High-grade research compounds must be accompanied by full spectrum RP-HPLC chromatograms showing purity levels exceeding 98.0%, alongside ESI-MS reports confirming the expected molecular weight without significant salt adducts or degradation products.
At PX1 Research, every batch of MOTS-c undergoes thorough analysis, including quantitative endotoxin determination via Limulus Amebocyte Lysate (LAL) testing to ensure levels remain below standard cell culture toxicity thresholds. All compounds are synthesized in USA-based, GMP-compliant facilities and verified by independent ISO 17025 accredited analytical laboratories, providing researchers with complete chemical transparency.
Lyophilized MOTS-c powder exhibits maximum stability when stored at -20°C or -80°C in a desiccated environment protected from light exposure. Prior to reconstitution, containers should be allowed to equilibrate to room temperature to prevent condensation of atmospheric moisture on the lyophilized cake.
For laboratory reconstitutions, investigators typically utilize sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4). Once reconstituted, liquid aliquots should be frozen immediately to avoid repeated freeze-thaw cycles, which accelerate peptide bond cleavage and aggregate formation. Detailed stability profiles and reconstitution guidelines are available in our central peptide research hub.
Selecting a reliable supplier involves balancing cost-efficiency with uncompromising quality assurance standards. PX1 Research eliminates supply chain ambiguity by shipping directly from domestic distribution centers in California and Arizona, offering same-day dispatch for orders placed Monday through Friday.
Principal investigators and institutional buyers managing large-scale preclinical projects can access custom volume pricing and lot-reservation options through a dedicated bulk research account. This structure ensures long-term access to single-lot inventories, minimizing experimental variance across extended longitudinal studies.
What factors primary determine the cost of MOTS-c peptide for research?
MOTS-c peptide cost is driven by synthesis complexity (16-amino acid sequence), post-synthesis preparative HPLC purification to achieve >98% purity, ESI-MS structural validation, quantitative endotoxin testing, and USA-based manufacturing standards.
What purity level should be expected for laboratory-grade MOTS-c?
For reliable in vitro and in vivo research, MOTS-c should feature a verified purity of ≥98% as determined by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Electrospray Ionization Mass Spectrometry (ESI-MS).
How is MOTS-c categorized among research peptides?
MOTS-c is classified as a mitochondrial-derived peptide (MDP), naturally encoded within the 12S rRNA gene of the mitochondrial genome, functioning as a nuclear-translocating metabolic signaling factor.
Does PX1 Research provide certificates of analysis for MOTS-c?
Yes. Every lot of MOTS-c supplied by PX1 Research includes a lot-specific Certificate of Analysis (COA) detailing RP-HPLC purity profiles, mass spectrometry verification, and endotoxin assay results from an ISO 17025 accredited laboratory.
What are the recommended storage conditions for lyophilized MOTS-c?
Lyophilized MOTS-c should be stored at -20°C or -80°C in a dry, dark environment. Reconstituted solutions should be divided into single-use aliquots and kept frozen to avoid degradation caused by freeze-thaw cycles.
What solvent is typically used to reconstitute MOTS-c for in vitro assays?
MOTS-c is commonly reconstituted using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on specific cell culture or assay buffer requirements.
Why is endotoxin testing critical when purchasing MOTS-c?
Bacterial endotoxins (LPS) can alter cell signaling, trigger inflammatory pathways, and skew metabolic parameters in experimental models. Strict endotoxin testing ensures that observed bioactivity is attributable solely to the MOTS-c peptide.
Where does PX1 Research ship MOTS-c peptide from?
All orders from PX1 Research ship directly from our facility locations in California and Arizona, ensuring rapid transit times and same-day dispatch for orders placed Monday through Friday.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.